Inhibitory receptors on eosinophils: a direct hit to a possible Achilles heel?
暂无分享,去创建一个
[1] L. Moretta,et al. Engagement of p75/AIRM1 or CD33 inhibits the proliferation of normal or leukemic myeloid cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[2] I. Bachelet,et al. The inhibitory receptor IRp60 (CD300a) suppresses the effects of IL-5, GM-CSF, and eotaxin on human peripheral blood eosinophils. , 2006, Blood.
[3] M. Daëron,et al. A Bispecific Antibody against Human Ige and Human Fcγrii That Inhibits Antigen-induced Histamine Release by Human Mast Cells and Basophils Hal-pasteur Author Manuscript , 2004 .
[4] O. Mandelboim,et al. 2B4 (CD244) Is Expressed and Functional on Human Eosinophils1 , 2005, The Journal of Immunology.
[5] David A. Williams,et al. CXCL9 inhibits eosinophil responses by a CCR3- and Rac2-dependent mechanism. , 2005, Blood.
[6] Megan E. McNerney,et al. A new self: MHC-class-I-independent Natural-killer-cell self-tolerance , 2005, Nature Reviews Immunology.
[7] B. Bochner,et al. Mechanism of Siglec-8-induced human eosinophil apoptosis: role of caspases and mitochondrial injury. , 2005, Biochemical and biophysical research communications.
[8] J. L. Kavanaugh,et al. Negative regulation of eosinophil recruitment to the lung by the chemokine monokine induced by IFN-γ (Mig, CXCL9) , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[9] J. Trowsdale,et al. You say ITAM and I say ITIM, let's call the whole thing off: the ambiguity of immunoreceptor signalling , 2006, European journal of immunology.
[10] P. Moore,et al. Identification, characterization and leucocyte expression of Siglec-10, a novel human sialic acid-binding receptor. , 2001 .
[11] Tominari Kobayashi,et al. T-cell activation and cytokine production via a bispecific single-chain antibody fragment targeted to blood-stage malaria parasites. , 2003, Blood.
[12] Min Zhang,et al. A novel human immunoglobulin Fcγ–Fcɛ bifunctional fusion protein inhibits FcɛRI-mediated degranulation , 2002, Nature Medicine.
[13] H. Broxmeyer,et al. Abnormal Chemokine-Induced Responses of Immature and Mature Hematopoietic Cells from Motheaten Mice Implicate the Protein Tyrosine Phosphatase Shp-1 in Chemokine Responses , 1999, The Journal of experimental medicine.
[14] G. Groenewegen,et al. Clinical evaluation of the bispecific antibody MDX-H210 (anti-FcγRI × anti-HER-2/neu) in combination with granulocyte-colony-stimulating factor (Filgrastim) for treatment of advanced breast cancer , 1997, Cancer Immunology, Immunotherapy.
[15] J. Phillips,et al. Identification of tyrosine residues crucial for CD200R‐mediated inhibition of mast cell activation , 2006, Journal of leukocyte biology.
[16] Nicolai V Bovin,et al. Glycan Array Screening Reveals a Candidate Ligand for Siglec-8* , 2005, Journal of Biological Chemistry.
[17] Hong Zhang,et al. The Src family kinases Hck and Fgr negatively regulate neutrophil and dendritic cell chemokine signaling via PIR-B. , 2005, Immunity.
[18] H. Rosenberg,et al. Eosinophils, eosinophil ribonucleases, and their role in host defense against respiratory virus pathogens , 2001, Journal of leukocyte biology.
[19] L. Álvarez-Vallina,et al. Antibodies and gene therapy: teaching old 'magic bullets' new tricks. , 2004, Trends in immunology.
[20] H. Katz. Inhibitory receptors and allergy. , 2002, Current opinion in immunology.
[21] D. Cosman,et al. Activation of human eosinophils through leukocyte immunoglobulin-like receptor 7 , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[22] M. Ono,et al. Modulation of Immune Complex–induced Inflammation In Vivo by the Coordinate Expression of Activation and Inhibitory Fc Receptors , 1999, The Journal of experimental medicine.
[23] L. Weiner,et al. Clinical development of 2B1, a bispecific murine monoclonal antibody targeting c-erbB-2 and Fc gamma RIII. , 1995, Journal of hematotherapy.
[24] I. Bachelet,et al. Reversal of airway inflammation and remodeling in asthma by a bispecific antibody fragment linking CCR3 to CD300a. , 2006, The Journal of allergy and clinical immunology.
[25] Kenneth G. C. Smith,et al. Cutting Edge: TREM-Like Transcript-1, a Platelet Immunoreceptor Tyrosine-Based Inhibition Motif Encoding Costimulatory Immunoreceptor that Enhances, Rather than Inhibits, Calcium Signaling via SHP-2 1 , 2004, The Journal of Immunology.
[26] A. Saxon,et al. A chimeric human-cat fusion protein blocks cat-induced allergy , 2005, Nature Medicine.
[27] L. Lanier,et al. Immune inhibitory receptors. , 2000, Science.
[28] I. Moura,et al. Identification of FcαRI as an Inhibitory Receptor that Controls Inflammation: Dual Role of FcRγ ITAM , 2005 .
[29] L. Moretta,et al. p75/AIRM1 and CD33, two sialoadhesin receptors that regulate the proliferation or the survival of normal and leukemic myeloid cells , 2001, Immunological reviews.
[30] L. Weiner,et al. Phase I Trial of 2B1, a Bispecific Monoclonal Antibody Targeting c-erbB-2 and FcγRIII , 1995 .
[31] Eric O Long,et al. Molecular basis for positive and negative signaling by the natural killer cell receptor 2B4 (CD244). , 2005, Blood.
[32] K. Spiekermann,et al. Surface and mRNA expression of the CD52 antigen by human eosinophils but not by neutrophils. , 1996, Blood.
[33] Wendy S. Becker,et al. Phase I clinical trial of the bispecific antibody MDX-H210 (anti-FcγRI × anti-HER-2/neu) in combination with Filgrastim (G-CSF) for treatment of advanced breast cancer , 2003, British Journal of Cancer.
[34] B. Bochner,et al. Ligation of Siglec-8: a selective mechanism for induction of human eosinophil apoptosis. , 2003, Blood.
[35] N. James,et al. A phase II study of the bispecific antibody MDX-H210 (anti-HER2 × CD64) with GM-CSF in HER2+ advanced prostate cancer , 2001, British Journal of Cancer.
[36] M. Neuberger,et al. Deficiency in CD22, a B Cell–specific Inhibitory Receptor, Is Sufficient to Predispose to Development of High Affinity Autoantibodies , 1999, The Journal of experimental medicine.